J.P. Morgan backs magnetic surgery maker GT Metabolic in Series C
What's the deal? GT Metabolic Solutions has raised a Series C growth investment led by J.P. Morgan Life Sciences Private Capital. The California-based medical device company builds magnetic compression systems that connect tubular structures in the body, such as intestines, without sutures or staples. The amount was not disclosed.
What does it do? Its linear magnetic anastomosis system creates incisionless, reversible gastrointestinal connections. Because it leaves no foreign material behind, the company says it preserves healing — a key difference from standard care — and works across endoscopic, robotic, or laparoscopic surgery.
Why it matters: Each year, up to 18% of GI anastomotic procedures result in life-threatening complications such as leaks and bleeding, which can lead to sepsis, readmission, or death. GT Metabolic says magnetic compression could cut those rates without sacrificing efficacy.
Why now? The raise follows a regulatory push. FDA records show GT Metabolic won additional 510(k) clearances in June and September 2026, building on its 2024 De Novo authorization for the MagDI system.
What's the endgame? Proceeds will fund the global commercial launch, surgeon training, and expansion into new settings — with endoscopic and colorectal surgery next. "This is an important milestone for GT Metabolic as we advance additional paradigm-shifting anastomotic products," said co-founder and chief executive officer Thierry Thaure.
The investor: This is GT Metabolic's first institutional financing partnership and the fifth investment by the J.P. Morgan Life Sciences Private Capital team. "The use of magnets in surgery is a game-changing technology to address serious adverse events," said Joe Siletto, managing partner at the firm.
The signal: The backing marks GT Metabolic's shift from regulatory milestones toward commercialization, with institutional capital behind it. The field is broadening too: competitor GI Windows has also won FDA clearances for magnetic compression devices, a sign the technology is moving beyond a single company.
Read more: markets.financialcontent.com
Image credit: Generated with Gemini
